Prestwick3_000358

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 21 USDMF, 4 JDMF, 1 EU WC, 5 NDC API, 4 Listed Suppliers, $ API Reference Price

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

157 FDF Dossiers, 93 FDA Orange Book, 6 Europe, 6 Canada, 2 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 6 SPI Pharma, 12 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Clariant, 7 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 23 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 12 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 33 Thickeners and Stabilizers, 33 Direct Compression, 28 Disintegrants & Superdisintegrants, 19 Granulation, 18 Solubilizers, 17 Coating Systems & Additives, 16 Lubricants & Glidants, 16 Co-Processed Excipients, 14 Taste Masking, 13 Topical, 10 Parenteral, 10 Film Formers & Plasticizers, 9 Rheology Modifiers, 8 Controlled & Modified Release, 8 Empty Capsules, 7 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 API Stability Enhancers, 3 Coloring Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

14 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 USP, 10 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50405 / DOSAGE - CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CEPHALEXIN(UNII: OBN7UDS42Y) (CEPHALEXIN ANHYDROUS - UNII:5SFF1W6677)	CEPHALEXIN ANHYDROUS	750mg \| 500mg \| 250mg

Inactive Ingredients

Ingredient Name	Pragma Pharmaceuticals, LLC	Shionogi Inc.	Fera Pharmaceuticals, LLC
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311)
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED(K679OBS311)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
D&C YELLOW NO. 10(35SW5USQ3G)
DIMETHICONE(92RU3N3Y1O)
FD&C BLUE NO. 1(H3R47K3TBD)
FD&C YELLOW NO. 6(H77VEI93A8)
GELATIN(2G86QN327L)
GELATIN, UNSPECIFIED(2G86QN327L)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Prestwick3_000358